SCHEMBL25864135

SCHEMBL25864135

CCOC(=O)C(OCC)P(=O)(OC)OC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.41
ALOX15 P16050 3/20 0.41
CYP3A4 P08684 2/20 0.41
TSHR P16473 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
HSD17B10 Q99714 2/20 0.37
CHRM1 P11229 1/20 0.37
ADORA1 P30542 1/20 0.37
LMNA P02545 3/20 0.35
CYP2C19 P33261 2/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
MGAM O43451 1/20 0.33
GAA P10253 1/20 0.33
SI P14410 1/20 0.33
MGAM2 Q2M2H8 1/20 0.33
SOAT1 P35610 1/20 0.33
POLB P06746 1/20 0.33
TRPA1 O75762 1/20 0.31
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28818287 0.88 LMNA (0.35) ALDH1A1ALOX15CYP3A4TSHRTDP1
SCHEMBL20122618 0.86 ALDH1A1 (0.42) ALDH1A1ALOX15CYP3A4TSHRTDP1
SCHEMBL331957 0.84 CYP3A4 (0.38) ALDH1A1ALOX15CYP3A4TSHRTDP1
SCHEMBL28008593 0.83 ACHE (0.35) TSHRLMNA
SCHEMBL28008585 0.82 LMNA (0.32) ALDH1A1ALOX15CYP3A4TSHRTDP1
SCHEMBL21562588 0.78 ALDH1A1 (0.37) ALDH1A1ALOX15CYP3A4TSHRTDP1
SCHEMBL6060005 0.78 ALDH1A1 (0.37) ALDH1A1ALOX15CYP3A4TSHRTDP1
SCHEMBL4421264 0.75 ALDH1A1 (0.43) ALDH1A1ALOX15CYP3A4TSHRTDP1
SCHEMBL5892273 0.74 CYP3A4 (0.40) ALDH1A1CYP3A4TSHRHSD17B10CYP2C19
SCHEMBL12631725 0.74 ALDH1A1 (0.34) ALDH1A1ALOX15CYP3A4TSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230234922-A1 PROCESSES FOR THE PREPARATION OF 4,6,7-TRIFLUORO-1H-INDOLE-2-CARBOXYLIC ACID ENANTA PHARMACEUTICALS, INC. 2023-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230234922-A1 PROCESSES FOR THE PREPARATION OF 4,6,7-TRIFLUORO-1H-INDOLE-2-CARBOXYLIC ACID ACE2, HTR3C, SARS1 ALDH1A1 1129/4885ALOX15 1967/4885CYP3A4 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.